Oracle (NYSE:ORCL) was in focus on Thursday as investment firm Argus raised its earnings estimates and upgraded the IT tech giant after it reported fiscal third-quarter results. Shares were flat in ...
SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- Synteract, a leading full service contract research organization (CRO), has implemented two Oracle® Argus 7.0 modules to its pharmacovigilance technology ...
Contract Research Organization aims to improve data management, accuracy, and safety with Oracle's AI-powered pharmacovigilance platform AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research ...
Argus, a financial analysis firm, has upgraded its price target for Oracle Corporation (NYSE: NYSE:ORCL) from $159.00 to $176.00 while maintaining a Buy rating on the shares. The firm highlighted ...
new and ever-changing pharmacovigilance and safety requirements. Efficient and effective management of these processes is vital from both a safety and business perspective," said Neil de Crescenzo, ...
On Thursday, Oracle Corporation (NYSE:ORCL) received an upgrade from a Hold to a Buy rating by a research analyst at Argus, with a new price target of $145.00. The upgrade comes following Oracle's ...
NEW DELHI--(BUSINESS WIRE)--APCER Life Sciences, the preferred pharmacovigilance (PV) services provider for pharmaceutical and biotech companies seeking compliance and safety management solutions ...
Hosted on MSN
Oracle’s share price surged by about 24% in one week
Oracle’s share price surged by about 24% this week, marking its strongest performance since April 2001, as investors reacted positively because of strong earnings and a positive outlook for its cloud ...
AUSTIN, Texas, July 8, 2025 -- Contract Research Organization (CRO), PrimeVigilance, is significantly enhancing its service offerings with Oracle Argus. Delivering the full lifecycle of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback